Target intelligence / Profile preview

PDZRN3 antisense RNA 1 (non-protein coding) (PDZRN3-AS1)

Target
PDZRN3-AS1
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

PDZRN3 antisense RNA 1 (PDZRN3-AS1) is a long non-coding RNA located on human chromosome 3 (genomic locus chr3:73621603-73627906, hg38). It does not encode a protein, but rather is likely involved in post-transcriptional and epigenetic regulation of gene expression, particularly that of its sense counterpart, PDZRN3, or associated pathways. Recent cancer transcriptome studies have identified PDZRN3-AS1 as one of several long non-coding RNAs differentially expressed in lung adenocarcinoma (LUAD), where its reduced expression correlates with patient prognosis and tumor invasion risk. Its functional and mechanistic roles remain to be fully elucidated, but current evidence suggests a potential role as a biomarker for cancer progression rather than as a direct therapeutic target. PDZRN3-AS1 is frequently misinterpreted as coding for the PDZRN3 E3 ligase enzyme or as a receptor—this is incorrect; PDZRN3-AS1 is strictly non-coding and distinct from PDZRN3 protein, which is itself an E3 ubiquitin ligase involved in protein trafficking, cell signaling, and junctional stability, but not an established therapeutic receptor or enzyme target as of this writing. No drugs are known to target PDZRN3-AS1, nor is a direct mechanism of drug action established for this lncRNA.

Other names
PDZRN3-AS1PDZRN3 antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expressionPotential involvement in cellular invasion (based on correlation with invasion genes in cancer)
03

Disease associations

Cancer (notably lung adenocarcinoma as a prognostic marker)
04

Biomarkers

Prognostic marker in lung adenocarcinoma (LUAD) for invasion and survival risk stratification

Beyond the preview

Go deeper on PDZRN3 antisense RNA 1 (non-protein coding) (PDZRN3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDZRN3 antisense RNA 1 (non-protein coding) (PDZRN3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call